Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Neoplasm Metastasis Clinical Trials Resources presented on Clinical Trials Search isn't designed to be a substitute for qualified healthcare advice, visits or professional assistance by using a real medical doctor. We aren't mDs. Always consult your physician about Neoplasm Metastasis conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Neoplasm Metastasis Clinical research trials and Neoplasm Metastasis health trials happen in a lot of of localities across the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new drugs. The function of the studies / undertakings is to resolve certain human health questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to discover treatments for all kinds of circumstances, including Neoplasm Metastasis. Neoplasm Metastasis Clinical Trials and other clinical trials allow volunteers to undergo health treatment alternatives before they are available to the masses. Most times the human subjects receive treatment for free of charge, and occasionally they are paid for their time. Occasionally there is a cost for a Neoplasm Metastasis clinical trial. Test subjects typically recieve the most expert healthcare available for their Neoplasm Metastasis affliction. Hazards are a reality, however, and may include additional or frequent dr. trips, healthcare dangers (potentially life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigid guidelines to protect clinical trials subjects.

Home > Clinical Trials by Conditions > "N" Clinical Trial Conditions > Neoplasm Metastasis Clinical Trials

Neoplasm Metastasis Clinical Trials



A Multimodality Treatment Approach to Patients with Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients with Metastatic Renal Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Infusional Chemotherapy with the P-Glycoprotein Antagonist PSC 833
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Intralesional Administration of an Adenovirus Vector Expressing the HSV-1 Thymidine Kinase Gene (AdV.RSV-TK) in Combination with Escalating Doses of Ganciclovir in Patients with Cutaneous Metastatic Malignant Melanoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Isolated Hepatic Perfusion with Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) with Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of OncoLARĀ® (Registered Trademark) (NSC 685403) with/without Tamoxifen in Patients with Osteosarcoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients with Refractory Metastatic Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of the Combination of Continuous Daily CAI and Intermittent Paclitaxel in Adult Patients with Refractory Cancers or Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Weekly Gemcitabine Given in Combination with Infusional Fluorouracil and Oral and Intravenous Calcium Leucovorin in Adult Cancer Patients
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I/II Trial of Vaccination with Mutant Ras Peptide Pulsed Dendritic Cells in the Treatment of HLA A2.1 Positive Patients with Colorectal Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase II Protocol of Flt3 Ligand in Patients with Metastatic Melanoma and Renal Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase II Study of Isolated Hepatic Perfusion (IHP) with Melphalan Followed by Postoperative Hepatic Arterial Chemotherapy Infusion for Metastatic Unresectable Colorectal Cancers of the Liver
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase II Trial of Trastuzumab and Paclitaxel in Patients with HER2 Overexpressing Breast and Ovarian Tumors Who Have Relapsed or Progressive Disease Following Conventional Cytotoxic Chemotherapy Regimens for Metastatic Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase III Multi-Institutional Randomized Study of Immunization with the gp100: 209-217 (210M) Peptide Followed by High Dose IL-2 vs. High Dose IL-2 Alone in Patients with Metastatic Melanoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients with Primary and Metastatic Brain Tumors
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Pilot Study of Paclitaxel/Cyclophosphamide and High Dose Melphalan/Etoposide with Autologous Progenitor Cell Transplantation for the Treatment of Metastatic and High Risk Breast Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Randomized Phase II Study of High Dose Ketoconazole Plus Alendronate Versus High Dose Ketoconazole in Patients with Androgen Independent Metastatic Prostate Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Randomized Three-Arm Study of the Treatment of Patients with Metastatic Renal Cell Carcinoma Using Low-Dose IL-2 and High-Dose IL-2
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Study of ALIMTA (pemetrexed) Plus Carboplatin for the Treatment of Patients with Locally Advanced or Metastatic Breast Cancer
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

ABX-EGF in Combination with Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)
Condition: immunex_corporation_clinical_trials.html
Immunex Corporation

ADI-PEG in Patients With Metastatic Melanoma
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene into Peripheral Blood Progenitor Cells Followed by Intensification Therapy with Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated with Dose-Intensive Chemotherapy
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Comparison of Two Kinds of Dendritic Cell Immunizations in Treating Melanoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Continuation Study of CpG 7909 in Patients with Stable Disease or Who Have Responded to Therapy for their Malignancies
Condition: coley_pharmaceutical_group_clinical_trials.html
Coley Pharmaceutical Group

Direct Injection of Alcohol for the Treatment of Spinal Tumors
Condition: national_institute_of_neurological_disorders_and_stroke_ninds_clinical_trials.html
National Institute of Neurological Disorders and Stroke (NINDS)

Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Efficacy and Safety of SU-011,248 in Patients with Anthracycline- and Taxane-Refractory Metastatic Breast Cancer
Condition: pfizer_clinical_trials.html
Pfizer

Feasibility Study of Interleukin 1-Alpha with Ifosfamide, CBDCA, and Etoposide with Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

For Prevention of Diarrhea in Patients Diagnosed with Metastatic Colorectal Cancer Treated with Chemotherapy
Condition: pfizer_clinical_trials.html
Pfizer

Gene Therapy for the Treatment of Brain Tumors
Condition: national_institute_of_neurological_disorders_and_stroke_ninds_clinical_trials.html
National Institute of Neurological Disorders and Stroke (NINDS)

gp100 and MART-1 Peptide Vaccine for Metastatic Melanoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Immunization of HLA-A201 Patients with Metastatic Melanoma Using a Combination of Immunodominant Peptides from Three Melanoma Antigens, MART-1, GP100 and Tyrosinase
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Immunization of Patients with Metastatic Melanoma Using DNA Encoding the GP100 Melanoma Antigen
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Immunization of Patients with Metastatic Melanoma Using Immunodominant Peptides from the Tyrosinase Protein, Tyrosinase Related Protein-1 (TRP1), or GP100 Protein
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Immunization of Patients with Metastatic Melanoma Using MART-1 and GP100 Peptides Modified to Increase Binding to HLA-0201
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Immunization of Patients with Metastatic Melanoma Using Recombinant Fowlpox and Vaccinia Viruses Encoding the Tyrosinase Antigen
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Immunization of Patients with Metastatic Melanoma Using Recombinant Fowlpox Virus Encoding a gp100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Immunization of Patients with Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Liver Perfusion of Melphalan in Inoperable Liver Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Oxaliplatin in Cancer Patients with Impaired Kidney Function
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Phase I Study in Patients with Metastatic Melanoma of Immunization with Dendritic Cells Presenting Epitopes Derived from the Melanoma Associated Antigen MART-1 and gp100
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Phase I Study of Noni in Cancer Patients
Condition: national_center_for_complementary_and_alternative_medicine_nccam_clinical_trials.html
National Center for Complementary and Alternative Medicine (NCCAM)

Phase I Study of PEG-Paclitaxel In Patients with Advanced Solid Tumors & Lymphomas
Condition: enzon_clinical_trials.html
Enzon

Phase I Trial in Patients with Metastatic Melanoma of Immunization with a Recombinant Fowlpox Virus Encoding the gp100 Melanoma Antigen
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Phase II trial of oral study drug in patients with advanced metastatic breast cancer who have experienced failure of an anthracycline, a taxane, and capecitabine
Condition: pfizer_clinical_trials.html
Pfizer

Photodynamic therapy with talaporfin sodium (LS11) in treating patients with refractory colorectal liver metastases
Condition: light_sciences_corporation_clinical_trials.html
Light Sciences Corporation



Neoplasm Metastasis Clinical Trials

Modify your Search

Neoplasm Metastasis Clinical Trials by State:

Alabama
Arizona
California
Colorado
Connecticut
District Of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kentucky
Louisiana
Maryland
Massachusetts
Michigan
Minnesota
Missouri
New Jersey
New York
North Carolina
North Dakota
Ohio
Pennsylvania
South Carolina
Tennessee
Texas
Washington
Wisconsin

Other "N" Clinical Trials Conditions:

Nail Patella Syndrome
Narcolepsy
Nasopharyngeal Cancer
Nausea
Nausea And Vomiting
Neck Cancer
Neck Pain
Necrotizing Enterocolitis
Needle Biopsy
Nematode Infection
Neonatal Jaundice
Neonatal Lupus
Neoplasm
Neoplasm By Histologic Type
Neoplasm Metastasis
Neoplasm Metastasis - Phase Ii
Neoplasms
Neoplasms, Gynecologic
Neoplasms, Hormone-Dependent
Neoplasms, Lung
Neoplasms, Solid Tumor
Neoplasms, Squamous Cell
Neoplastic Syndromes, Hereditary
Nephritis
Nephroblastoma
Nephrosis
Nephrotic Syndrome
Nervous System Anomalies
Nervous System Disease
Nervous System Diseases
Nervous System Heredodegenerative Disorder
Nervous System Malformations
Neural Tube Defects
Neuralgia
Neuritis
Neurobehavioral Manifestation
Neuroblastoma
Neurocardiogenic Syncope
Neurodegenerative Disease
Neuroectodermal Tumor, Primitive
Neuroendocrine Carcinoma
Neuroendocrine Tumor
Neuroendocrine Tumors
Neuroepithelioma
Neurofibroma, Plexiform
Neurofibromatosis 1
Neurofibromatosis 1 And 2 (nf1 And Nf2)
Neurofibromatosis 2
Neurofibromatosis Type I
Neurologic Abnormalities
Neurologic Diseases, General
Neurologic Disorders
Neurologic Manifestations
Neurological Disorder
Neurological Disorders
Neuromuscular Disease
Neuromuscular Diseases
Neuronal Migration Disorders
Neurosyphilis
Neurotoxicity
Neutropenia
Nevoid Basal Cell Carcinoma Syndrome
Nevus
Newly Diagnosed Carcinoma Of Unknown Primary
Newly Diagnosed Childhood Ependymoma
Nicotine Dependence
Nicotine Replacement Therapy
Niemann Pick Disease
Niemann-Pick Disease
Nitric Oxide
Non Hodgkin's Lymphoma
Non Insulin Dependent Diabetes Mellitus
Non Small Cell Lung Ca
Non Small Cell Lung Cancer
Non Small Cell Lung Carcinoma
Non-Hematologic Neoplasms
Non-Hodgkin Lymphoma
Non-Hodgkin's Lymphoma
Non-Hodgkins Lymphoma
Non-Insulin Dependent
Non-Insulin-Dependent Diabetes Mellitus
Non-Obstructive Azoospermia
Non-Small Cell Lung Cancer
Non-Small-Cell Lung Cancer
Non-Small-Cell Lung Carcinoma
Non-T, Non-B Adult Acute Lymphoblastic Leukemia
Non-T, Non-B Childhood Acute Lymphoblastic Leukemia
Nonalcoholic Steatohepatitis
Noncontiguous Stage 2 Adult Diffuse Large Cell Lymphoma
Noncontiguous Stage 2 Adult Diffuse Small Noncleaved Cell/burkitt's Lymphoma
Noncontiguous Stage 2 Adult Lymphoblastic Lymphoma
Noncontiguous Stage 2 Diffuse Small Lymphocytic/marginal Zone Lymphoma
Noncontiguous Stage 2 Grade I Follicular Small Cleaved Cell Lymphoma
Noncontiguous Stage 2 Grade Ii Follicular Mixed Cell Lymphoma
Noncontiguous Stage 2 Mantle Cell Lymphoma
Nonmelanoma Skin Cancer
Nonmetastatic Childhood Soft Tissue Sarcoma
Nonmetastatic Gestational Trophoblastic Tumor
Nonseasonal Depression
Nose Cancer
Nose Cancers
Nsclc
Nutrition
Nyha Class Ii, Iii Or Iv Chf
Nystagmus


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103